High sensitivity detection of EGFR exon 20 T790M and C797S mutations using ICE COLD-FOR

被引:0
|
作者
Wu, Grant
Jensen, Sheena
Scott, Karissa
Montagne, Erin
Stoddard, Jason
Krzycki, Phil
Schweikart, Courtney
Legendre, Benjamin L.
Eastlake, Philip
Richardson, Katherine A.
机构
关键词
D O I
10.1158/1538-7445.AM2016-1390
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1390
引用
收藏
页数:4
相关论文
共 50 条
  • [31] T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study
    Wang, Linxiao
    Fan, Dang
    Ruan, Wei
    Huang, Xiaoling
    Zhu, Wufu
    Tu, Yuanbiao
    Zheng, Pengwu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (06): : 3144 - 3155
  • [33] Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation
    Su, Zhicheng
    Yang, Tingyuan
    Wang, Jie
    Lai, Mengzhen
    Tong, Linjiang
    Wumaier, Gulinuer
    Chen, Zhuo
    Li, Shengqing
    Li, Honglin
    Xie, Hua
    Zhao, Zhenjiang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (16)
  • [34] Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
    Kenneth S Thress
    Cloud P Paweletz
    Enriqueta Felip
    Byoung Chul Cho
    Daniel Stetson
    Brian Dougherty
    Zhongwu Lai
    Aleksandra Markovets
    Ana Vivancos
    Yanan Kuang
    Dalia Ercan
    Sarah E Matthews
    Mireille Cantarini
    J Carl Barrett
    Pasi A Jänne
    Geoffrey R Oxnard
    Nature Medicine, 2015, 21 : 560 - 562
  • [35] The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations
    Kagawa, Yosuke
    Hayashida, Takuma
    Liu, Jie
    Mori, Shunta
    Izumi, Hiroki
    Kumagai, Shogo
    Udagawa, Hibiki
    Hattori, Noboru
    Goto, Koichi
    Kobayashi, Susumu S.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (03):
  • [36] CH7233163, a mutantselective EGFR inhibitor, overcomes osimertinib resistant EGFR-T790M/C797S
    Kashima, Kenji
    CANCER RESEARCH, 2020, 80 (16)
  • [37] Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
    Thress, Kenneth S.
    Paweletz, Cloud P.
    Felip, Enriqueta
    Cho, Byoung Chul
    Stetsonl, Daniel
    Dougherty, Brian
    Lai, Zhongwu
    Markovets, Aleksandra
    Vivancos, Ana
    Kuang, Yanan
    Ercan, Dalia
    Matthews, Sarah E.
    Cantarini, Mireille
    Barrett, J. Carl
    Jaenne, Pasi A.
    Oxnard, Geoffrey R.
    NATURE MEDICINE, 2015, 21 (06) : 560 - 562
  • [38] TAS3351, a fourth-generation brain-penetrating EGFR inhibitor designed to target common EGFR mutations, including those with or without T790M and C797S resistance mutations
    Iwasaki, J.
    Kasuga, H.
    Kataoka, Y.
    Muraoka, H.
    Yamamoto, F.
    Tsuji, S.
    Tanaka, S.
    Hashimoto, A.
    Miyamoto, R.
    Mizuarai, S.
    Ohkubo, S.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S26 - S28
  • [39] BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC
    Schalm, S. S.
    Dineen, T.
    Lim, S. M.
    Park, C-W.
    Hsieh, J.
    Woessner, R.
    Zhang, Z.
    Wilson, K.
    Eno, M.
    Wilson, D.
    Williams, B.
    Campbell, J.
    De Savi, C.
    Stevison, F.
    Utt, C.
    Guzi, T.
    Dorsch, M.
    Hoeflich, K.
    Cho, B. C. Chul
    ANNALS OF ONCOLOGY, 2020, 31 : S839 - S839
  • [40] BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC
    Schalm, S. S.
    Dineen, T.
    Lim, S. M.
    Park, C. W.
    Hsieh, J.
    Woessner, R.
    Zhang, Z.
    Wilson, K.
    Eno, M.
    Wilson, D.
    Williams, B.
    Campbell, J.
    de Savi, C.
    Stevison, F.
    Utt, C.
    Guzi, T.
    Dorsch, M.
    Hoeflich, K.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1391 - S1391